Please provide your email address to receive an email when new articles are posted on . With the exception of the eventual, however begrudging, acceptance of dry eye disease as a thing, the biggest ...
For optometrists, 2026 provides ample opportunity to continue the charge in advancements in dry eye, artificial intelligence ...
Please provide your email address to receive an email when new articles are posted on . The health and vitality of the ocular surface are largely dependent on the protective and lubricating properties ...
Meibomian gland dysfunction (MGD) is underdiagnosed and undertreated, with asymptomatic disease far more common than symptomatic disease. As the condition progresses, patients who were initially ...
A systematic review found that there were currently a limited number of clinical trials evaluating treatment for dry eye disease (DED) that is associated with meibomian gland dysfunction (MGD). Future ...
IRVINE, Calif., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize ...
Dry eye disease (DED) affects nearly 16 million Americans. This multifactorial condition, characterized by rapid tear evaporation or decreased tear production, can cause symptoms from eye irritation ...
Label expansion for evaporative dry eye due to MGD will support further efforts to drive patient access to insurance-covered TearCare treatments MENLO PARK, Calif., Dec. 22, 2021 (GLOBE NEWSWIRE) -- ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results